1-12 of 12
Lynn O'Donnell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results of a First-in-Human, Phase I Study Point-of-Care Manufacturing of Trispecific CAR-T Cells Targeting CD19/20/22 in B-Cell Malignancies

Sumithira Vasu, Evandro Bezerra, Nathan Denlinger, Nicole Szuminski, Dina Schneider, Pradyot Dash, Louisa Wirthlin, Narendranath Epperla, Yazeed Sawalha, Jennifer A. Woyach, Kerry A. Rogers, Seema A Bhat, Gregory K Behbehani, Karilyn T. Larkin, Adam S Kittai, Wing Chan, Ashley Angell Krull, Shamama Nishat, Lynn O'Donnell, Lapo Alinari, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 2078.
https://doi.org/10.1182/blood-2024-207532
Published: 2024
Journal Articles

Spatial Tissue Analysis of Secondary Sarcoma Following CAR T Cell Therapy for B Cell Lymphoma

Dina Schneider, Jia-Jye Lee, Jinling Wang, Robert Pinard, Peirong Hu, Kun Luo, Ngoc Tran, Yazeed Sawalha, Nathan Denlinger, Evandro Bezerra, Pradyot Dash, Ashley Angell Krull, Lynn O'Donnell, Lapo Alinari, Dan Jones, Marcos de Lima, Sumithira Vasu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7139.
https://doi.org/10.1182/blood-2024-203633
Published: 2024
Journal Articles

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Yvonne Efebera, Lynn O'Donnell, Ashley E Rosko, Sumithira Vasu, Marcos de Lima, Don Benson, Srinivas Devarakonda
Journal: Blood
Blood (2023) 142 (Supplement 1): 911.
https://doi.org/10.1182/blood-2023-184904
Published: 2023
Journal Articles

A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)

Sumithira Vasu, Lapo Alinari, Nicole Szuminski, Dina Schneider, Nathan Denlinger, Wing Keung Chan, Khalid Parris, Nidhi Sharma, Hillary Bradbury, Beth Daneault, Lynn O'Donnell, Boro Dropulic, Marcos J.G. de Lima
Journal: Blood
Blood (2022) 140 (Supplement 1): 7474–7475.
https://doi.org/10.1182/blood-2022-167340
Published: 2022
Journal Articles

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

David J. Chung, Nina Shah, Dina Stroopinsky, Juan WU, Lina Bisharat, Natalie S. Callander, Brent R. Logan, Kenneth C. Anderson, Thinle Chodon, Meera Mohan, Steven Devine, Yvonne A. Efebera, Nancy Geller, Peiman Hematti, Leona A. Holmberg, Alan Howard, Bryon Johnson, Hillard M Lazarus, Ehsan Malek, Philip L. McCarthy, David H. McKenna, Adam M. Mendizabal, Nikhil C. Munshi, Lynn O'Donnell, Aaron P. Rapoport, Ajay K. Nooka, Jane Reese, Robert J. Soiffer, Lynne Uhl, Giulia Cheloni, Dimitra Karagkouni, Ioannis Vlachos, James W. Young, Jacalyn Rosenblatt, Edmund K. Waller, Marcelo C Pasquini, David Avigan
Journal: Blood
Blood (2021) 138 (Supplement 1): 899.
https://doi.org/10.1182/blood-2021-149659
Published: 2021
Journal Articles

A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sumithira Vasu, Nidhi Sharma, Alison R. Walker, Sarah A Wall, James S. Blachly, Greg K. Behbehani, Hannah Choe, Aarohi Thakkar, Robin Nakkula, Ella Troy, Nicole Szuminski, Marcos J.G. de Lima, Lynn O'Donnell, Dean Anthony Lee
Journal: Blood
Blood (2021) 138 (Supplement 1): 1732.
https://doi.org/10.1182/blood-2021-150750
Published: 2021
Journal Articles

A Pilot Phase I Trial of IL-21 Expanded Ideal-Donor Natural Killer (NK) Cells in Combination with Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas (CTCL) or Adult T-Cell Leukemia/Lymphomas (ATLL)

Basem M. William, John C. Reneau, Amanda Campbell, Anna Vilgelm, Michelle Watts, Lynn O'Donnell, Ying Huang, Catherine Chung, Marcos J.G. de Lima, Steven Devine, Sumithira Vasu, Dean Anthony Lee
Journal: Blood
Blood (2021) 138 (Supplement 1): 1388.
https://doi.org/10.1182/blood-2021-150543
Published: 2021
Journal Articles

A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Off-the-Shelf, Third-Party Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sumithira Vasu, MDMBBS, Bhavana Bhatnagar, DO, James S. Blachly, MD, Nicole Szuminski, BS, Lynn O'Donnell, PhD, Dean Anthony Lee, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44.
https://doi.org/10.1182/blood-2020-139170
Published: 2020
Journal Articles

Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-g Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449)

Allyson M. Flower, MD, Rachel Friedmann, DO, Janet Ayello, MS, MT(ASCP), Olivia Rigot, PhD, Lauren Harrison, RN, MSN, Erin Morris, RN, BSN, Meghan Sturhahn, RN, MSN, Elana Maryamchik, MD, Yongping Wang, MD, Lynn O'Donnell, PhD, Rolla Abu-Arja, MD, Dean Anthony Lee, MD PhD, Julie-An Talano, MD, Bryon Johnson, PhD, Nancy Bunin, MD, Mitchell S Cairo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
https://doi.org/10.1182/blood-2020-140834
Published: 2020
Journal Articles

Cytomegalovirus Reactivation Does Not Increase Subsequent Risk for Acute Graft-Versus-Host Disease, Malignant Disease Relapse, or Infection Following Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3409.
https://doi.org/10.1182/blood.V128.22.3409.3409
Published: 2016
Journal Articles

Early Infection Attenuates Hematologic Malignant Disease Relapse Following Initial Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3410.
https://doi.org/10.1182/blood.V128.22.3410.3410
Published: 2016
Journal Articles

Determination of Optimal Target Antigen and Immune Modulatory Approaches to Improve and Standardize Epstein-Barr Virus-Specific Adoptive T Cell Therapy

Monica L Mitchell, John T. Patton, PhD, Lynn O'Donnell, PhD, Robert A. Baiocchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5817.
https://doi.org/10.1182/blood.V124.21.5817.5817
Published: 2014